Important international and Chinese clinical trials on gastric cancer.
- Author:
Aiwen WU
1
;
Rulin MIAO
;
Jiafu JI
Author Information
1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Gastrointestinal Cancer Center, Peking University Cancer Hospital and Institute, Beijing 100142, China. wuaw@sina.com.
- Publication Type:Journal Article
- MeSH:
Clinical Trials as Topic;
Combined Modality Therapy;
Humans;
Laparoscopy;
Stomach Neoplasms;
surgery
- From:
Chinese Journal of Gastrointestinal Surgery
2016;19(2):151-156
- CountryChina
- Language:Chinese
-
Abstract:
In the era of evidence-based medicine, the diagnosis and treatment of gastric cancer are based on the evidence from important clinical trials. International and Chinese trials are performed on early, locally advanced, and late stage gastric cancer and the key points of trials of each aspect are different. Clinical trials of early gastric cancer mainly focus on the minimally invasive treatments like endoscopic resection and laparoscopic surgery. Clinical trials of locally advanced gastric cancer aim to raise the extent of radical treatment and multimodality treatment patterns. As to late stage gastric cancer, the trials aiming to prolong survival of the patients, conversion treatment, target therapy, immune therapy and new drug development are mostly interested.
